Cargando…

Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome

Background: Patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSAS) overlap syndrome (OS) are thought to be at increased risk for cardiovascular diseases. Objective: To evaluate the burden of cardiovascular diseases and long-term outcomes in patients with OS. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Manyun, Wang, Yidan, Wang, Mengjie, Tong, Rui, Shi, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576345/
https://www.ncbi.nlm.nih.gov/pubmed/34764876
http://dx.doi.org/10.3389/fphar.2021.767982
_version_ 1784595857663852544
author Tang, Manyun
Wang, Yidan
Wang, Mengjie
Tong, Rui
Shi, Tao
author_facet Tang, Manyun
Wang, Yidan
Wang, Mengjie
Tong, Rui
Shi, Tao
author_sort Tang, Manyun
collection PubMed
description Background: Patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSAS) overlap syndrome (OS) are thought to be at increased risk for cardiovascular diseases. Objective: To evaluate the burden of cardiovascular diseases and long-term outcomes in patients with OS. Methods: This was a retrospective cohort study. The prevalence of cardiovascular diseases and 1-year mortality were compared among patients diagnosed with OS (OS group), COPD alone (COPD group) and OSAS alone (OSAS group), and Cox proportional hazards models were used to assess independent risk factors for all-cause mortality. Results: Overall, patients with OS were at higher risk for pulmonary hypertension (PH), heart failure and all-cause mortality than patients with COPD or OSAS (all p < 0.05). In multivariate Cox regression analysis, the Charlson comorbidity index (CCI) score [adjusted hazard ratio (aHR): 1.273 (1.050–1.543); p = 0.014], hypertension [aHR: 2.006 (1.005–4.004); p = 0.048], pulmonary thromboembolism (PTE) [aHR: 4.774 (1.335–17.079); p = 0.016] and heart failure [aHR: 3.067 (1.521–6.185); p = 0.002] were found to be independent risk factors for 1-year all-cause mortality. Conclusion: Patients with OS had an increased risk for cardiovascular diseases and 1-year mortality. More efforts are needed to identify the causal relationship between OS and cardiovascular diseases, promoting risk stratification and the management of these patients.
format Online
Article
Text
id pubmed-8576345
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85763452021-11-10 Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome Tang, Manyun Wang, Yidan Wang, Mengjie Tong, Rui Shi, Tao Front Pharmacol Pharmacology Background: Patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSAS) overlap syndrome (OS) are thought to be at increased risk for cardiovascular diseases. Objective: To evaluate the burden of cardiovascular diseases and long-term outcomes in patients with OS. Methods: This was a retrospective cohort study. The prevalence of cardiovascular diseases and 1-year mortality were compared among patients diagnosed with OS (OS group), COPD alone (COPD group) and OSAS alone (OSAS group), and Cox proportional hazards models were used to assess independent risk factors for all-cause mortality. Results: Overall, patients with OS were at higher risk for pulmonary hypertension (PH), heart failure and all-cause mortality than patients with COPD or OSAS (all p < 0.05). In multivariate Cox regression analysis, the Charlson comorbidity index (CCI) score [adjusted hazard ratio (aHR): 1.273 (1.050–1.543); p = 0.014], hypertension [aHR: 2.006 (1.005–4.004); p = 0.048], pulmonary thromboembolism (PTE) [aHR: 4.774 (1.335–17.079); p = 0.016] and heart failure [aHR: 3.067 (1.521–6.185); p = 0.002] were found to be independent risk factors for 1-year all-cause mortality. Conclusion: Patients with OS had an increased risk for cardiovascular diseases and 1-year mortality. More efforts are needed to identify the causal relationship between OS and cardiovascular diseases, promoting risk stratification and the management of these patients. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576345/ /pubmed/34764876 http://dx.doi.org/10.3389/fphar.2021.767982 Text en Copyright © 2021 Tang, Wang, Wang, Tong and Shi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tang, Manyun
Wang, Yidan
Wang, Mengjie
Tong, Rui
Shi, Tao
Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title_full Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title_fullStr Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title_full_unstemmed Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title_short Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
title_sort risk for cardiovascular disease and one-year mortality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome overlap syndrome
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576345/
https://www.ncbi.nlm.nih.gov/pubmed/34764876
http://dx.doi.org/10.3389/fphar.2021.767982
work_keys_str_mv AT tangmanyun riskforcardiovasculardiseaseandoneyearmortalityinpatientswithchronicobstructivepulmonarydiseaseandobstructivesleepapneasyndromeoverlapsyndrome
AT wangyidan riskforcardiovasculardiseaseandoneyearmortalityinpatientswithchronicobstructivepulmonarydiseaseandobstructivesleepapneasyndromeoverlapsyndrome
AT wangmengjie riskforcardiovasculardiseaseandoneyearmortalityinpatientswithchronicobstructivepulmonarydiseaseandobstructivesleepapneasyndromeoverlapsyndrome
AT tongrui riskforcardiovasculardiseaseandoneyearmortalityinpatientswithchronicobstructivepulmonarydiseaseandobstructivesleepapneasyndromeoverlapsyndrome
AT shitao riskforcardiovasculardiseaseandoneyearmortalityinpatientswithchronicobstructivepulmonarydiseaseandobstructivesleepapneasyndromeoverlapsyndrome